Company Name:AxoGen, Inc.
CEO: Karen L. Zaderej

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.


Key numbers

Market Capitalization:449707089
Shares Outstanding: 39761900
Float: 35893584
Next Earning Date:2020-08-05
TTm EPS: -0.7055
TTm Dividend Rate:
200 days moving average:12.13
50 days moving average: 10.29
One day percent Change: -0.26



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,